Skip to content
healthcare.dev

Fulvestrant

NDC 83634-203, fulvestrant, injection, solution, from Avenacy, Inc..

Product NDC
83634-203
Status
Listed
Labeler
Avenacy, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211422
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83634-203 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
83634-203-74836340203742 SYRINGE, GLASS in 1 CARTON (83634-203-74) / 5 mL in 1 SYRINGE, GLASS (83634-203-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f44cffcc-8f5e-4a4c-a36e-ab946ce86266
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83634-203

Use it

Look up 83634-203 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83634-203 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83634-203. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.